Hopman Mark sold BBNX
June 24, 2026 · Form 4 insider transaction
Hopman Mark sold 1,258 shares of Beta Bionics, Inc. at $15.01 per share, a transaction worth $18.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,258
Price
$15.01
Total value
$18.9K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 24, 2026
Filing dateJune 25, 2026
Shares owned after129,354
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.; The weighted average sale price for the transaction reported was $15.0083 and the range of prices were between $15.00 and $15.015. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.